Evidence map›Paper›PMID 31820522›Full record

ArticleCell proliferation2020

Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.

Jin Zhou, Yuan-Yuan Jiang, Huan Chen, Yi-Chao Wu, Li Zhang

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Cell proliferation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 162 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed, 1 pooled it
19.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 1 synthesis or guideline pooled it, 349 citations in OpenAlex.

  1. Prognostic significance of autophagy-related genesThe Journal of international medical research · 2020
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Apoptotic body-encapsulated zinc-dopedMaterials today. Bio · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Chinese herbal medicines · 2025
    Article
  18. Article
  19. Article
  20. Article

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jin ZhouCollege of Science, Sichuan Agricultural University, Ya'an, China.
Yuan-Yuan JiangCollege of Science, Sichuan Agricultural University, Ya'an, China.
Huan ChenCollege of Science, Sichuan Agricultural University, Ya'an, China.
Yi-Chao WuCollege of Life Science, China West Normal University, Nanchong, China.
Li ZhangCollege of Science, Sichuan Agricultural University, Ya'an, China.ORCID https://orcid.org/0000-0003-2196-2180
Sichuan Agricultural University · CNChina West Normal University · CN

Funding

Sichuan Crops and Animals Breeding Special Project 2016NYZ0036Sichuan Science and Technology Program 2018TJPT0013Sichuan Science and Technology Program 2019YFS0021
6 · The paper itself

Abstract

objectivesTanshinone I (Tan-I) is one of the vital fatsoluble monomer components, which extracted from Chinese medicinal herb Salvia miltiorrhiza Bunge. It has been shown that Tan-I exhibited anti-tumour activities on different types of cancers. However, the underlying mechanisms by which Tan-Ⅰ regulates apoptosis and autophagy in ovarian cancer remain unclear. Thus, this study aimed to access the therapy effect of Tan-Ⅰ and the underlying mechanisms.

methodsOvarian cancer cells A2780 and ID-8 were treated with different concentrations of Tan-Ⅰ (0, 1.2, 2.4, 4.8 and 9.6 μg/mL) for 24 hours. The cell proliferation was analysed by CCK8 assay, EdU staining and clone formation assay. Apoptosis was assessed by the TUNEL assay and flow cytometry. The protein levels of apoptosis protein (Caspase-3), autophagy protein (Beclin1, ATG7, p62 and LC3II/LC3I) and PI3K/AKT/mTOR pathway were determined by Western blot. Autophagic vacuoles in cells were observed with LC3 dyeing using confocal fluorescent microscopy. Anti-tumour activity of Tan-Ⅰ was accessed by subcutaneous xeno-transplanted tumour model of human ovarian cancer in nude mice. The Ki67, Caspase-3 level and apoptosis level were analysed by immunohistochemistry and TUNEL staining.

resultsTan-Ⅰ inhibited the proliferation of ovarian cancer cells A2780 and ID-8 in a dose-dependent manner, based on CCK8 assay, EdU staining and clone formation assay. In additional, Tan-Ⅰ induced cancer cell apoptosis and autophagy in a dose-dependent manner in ovarian cancer cells by TUNEL assay, flow cytometry and Western blot. Tan-Ⅰ significantly inhibited tumour growth by inducing cell apoptosis and autophagy. Mechanistically, Tan-Ⅰ activated apoptosis-associated protein Caspase-3 cleavage to promote cell apoptosis and inhibited PI3K/AKT/mTOR pathway to induce autophagy.

conclusionsThis is the first evidence that Tan-Ⅰ induced apoptosis and promoted autophagy via the inactivation of PI3K/AKT/mTOR pathway on ovarian cancer and further inhibited tumour growth, which might be considered as effective strategy.

Indexed as

AbietanesAnimalsAntineoplastic Agents, PhytogenicApoptosisAutophagyCaspase 3Cell Line, TumorCell ProliferationCell SurvivalFemaleHumansMiceMice, Inbred BALB CMice, NudeOvarian NeoplasmsPhosphatidylinositol 3-KinasesAbietanesAntineoplastic Agents, PhytogenicCaspase 3MTOR protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akttanshinoneTOR Serine-Threonine KinasesAKTapoptosisAutophagymTORovarian cancerPI3KTanshinone Ⅰ

Identifiers

PMID31820522
PMCPMC7046305
OpenAlexW2995859967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.